UCEF III Archives

NeoPhore

NeoPhore is focused on the discovery and development of novel small molecule therapies to treat cancer through stimulation of the immune system. NeoPhore’s drug target rationale is highly validated by genetic evidence in cancer patients and cellular models…. Read More

Healthera

Healthera Ltd, a provider of next-generation, pharmacy-integrated personal health management solutions, has secured seed investment from the University of Cambridge, the University of Cambridge Enterprise Fund III, FT Capital and high net worth individuals. The specific amounts are… Read More

8Power

8Power is a University of Cambridge start-up developing novel technology for sensing and measurement in industrial applications. The University of Cambridge is a world leader in the science and technology of sensing, and is pioneering the research of new… Read More

Cambridge Touch Technologies

Cambridge Touch Technologies (CTT) is a University of Cambridge start-up developing next-gen 3D touch technology. CTT’s next generation 3D touch technology enables mobile devices to sense both the location and force of multi-touch inputs. CTT’s technology improves on… Read More

Silicon Microgrvity

Spun-out of the University of Cambridge Nanoscience Centre, Silicon Microgravity is commercialising a sensor technology which provides a breakthrough in the management of oil and gas reservoirs. The company’s breakthrough sensing technology combines the recording of gravity data at… Read More

Cytora

Founded in early 2013, Cytora has built an event detection technology that can detect factual, real world events in unstructured text. The technology can be scaled to cover all major event categories and be monetised across the Financial… Read More

Quethera

Quethera, a spin-out from the University of Cambridge, is a gene therapy company developing a novel treatment for glaucoma. The company aims to deliver gene products for neuroprotectants and their receptors directly to the eye, which will provide long term… Read More

Reduse

The Parkwalk-managed University of Cambridge Enterprise Fund III invested in Reduse in June 2015. In October 2016 the company entered voluntary liquidation. Reduse, a spin out from the Low Carbon Materials Processing Group at the University of Cambridge,… Read More

PhoreMost

PhoreMost has developed a next-generation phenotypic screening platform called ‘Site-Seeker’ to identify the best new targets for future therapy, and crucially, how to drug them. This has the potential to significantly increase the diversity of novel therapeutics for… Read More

RoadMap

RoadMAp – silicon wavelength switch technology

AQDOT

Aqdot‘s technology allows for an energy- and raw material-efficient way of manufacturing microcapsules, leading to lower energy consumption and less waste.

Sphere Fluidics

Sphere Fluidics has developed unique products for use in single cell analysis and characterisation and provides collaborative R&D services.

Cambridge CMOS Sensors

In June 2016 Cambridge CMOS Sensors was acquired by ams AG in an all-cash confidential transaction. This resulted in multiple returns for Parkwalk investors. Cambridge CMOS Sensors is a leading manufacturer of sensor solutions for monitoring air quality, with… Read More